RBMS2 and breast carcinoma: As demonstrated in Fig. 1G and Fig. 1I, after DOX treatment, the ability of RBMS2 overexpressed breast cancer cells to form colonies was much worse than that of control cells, while inhibition of RBMS2 impaired the proliferation of breast cancer to a much lesser extent (Fig. 1H, J).